YIH
MXCT icon

Y-Intercept (HK)’s MaxCyte MXCT Stock Holding History

Y-Intercept (HK)’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.8K Buy
+23,436
New +$23.4K ﹤0.01% 1639

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Y-Intercept (HK)'s MXCT Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in MaxCyte (MXCT) in Q2 2026: 23,436 shares worth $28.8K. The stake represents ﹤0.01% of the portfolio and ranks #1639 among its holdings.

123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Y-Intercept (HK) held 23,436 shares of MaxCyte worth $28.8K as of Q2 2026.
  • MaxCyte was a new Y-Intercept (HK) position in Q2 2026.
  • MaxCyte made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1639 holding.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.